Medscape

FDA Okays IM Administration for Peginterferon Beta-1a in MS

The US Food and Drug Administration (FDA) has approved intramuscular (IM) administration of peginterferon β-1a (Plegridy, Biogen) for patients with relapsing forms of multiple sclerosis (MS). "The new ...

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care

Rafa Laboratoriesis adopting a robust and integrated product development approach, which is planned to include formulation development, manufacturing scale-up, pre/clinical trials and a streamlined ...
Monthly Prescribing Reference

Intramuscular Administration of HIV Treatment Ibalizumab Compared With IV Infusion

Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
Seeking Alpha

Theratechnologies says Trogarzo IM method of administration study did not meet primary endpoint

Biopharma Theratechnologies (NASDAQ:THTX) Friday announced that a study evaluating an intramuscular (IM) method of administration for its therapy, Trogarzo, did not meet the primary endpoint. "The ...
Nasdaq

Biogen Says FDA Approves PLEGRIDY Intramuscular Administration For MS - Quick Facts

(RTTNews) - Biogen Inc. (BIIB) said Monday that the U.S. Food and Drug Administration has approved a new intramuscular (IM) injection route of administration for PLEGRIDY (peginterferon beta-1a) for ...
Nasdaq

Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19

LONDON and SAN FRANCISCO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced headline data from the randomized, ...